These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 10226229)

  • 1. Twenty-four-hour ambulatory blood pressure monitoring in the evaluation of antihypertensive drugs: methodological aspects.
    Chamontin B
    Blood Press Monit; 1996 Jun; 1(3):213-216. PubMed ID: 10226229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aims of ambulatory blood pressure monitoring during phase II and III clinical trials.
    Andréjak MJ
    Blood Press Monit; 1996 Jun; 1(3):309-311. PubMed ID: 10226251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ambulatory blood pressure monitoring and clinical trials].
    Andréjak M; Mallion JM; Asmar R; Chau NG; de Gaudemaris R; Drici M; Herpin D; Poncelet P
    Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1175-8. PubMed ID: 8572868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical value of ambulatory blood pressure monitoring in the assessment of antihypertensive therapy.
    Waeber B; Brunner HR
    Blood Press Monit; 1999 Oct; 4(5):263-6. PubMed ID: 10547648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ambulatory monitoring of the blood pressure in multicenter clinical trials.
    White WB; Walsh SJ
    Blood Press Monit; 1996 Jun; 1(3):227-229. PubMed ID: 10226232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The placebo effect in ambulatory blood pressure monitoring.
    Coca A
    Blood Press Monit; 1998 Jun; 3(3):195199. PubMed ID: 10212357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conduct of therapeutic trials.
    Perloff D
    Blood Press Monit; 1996 Jun; 1(3):255-257. PubMed ID: 10226239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of ambulatory blood pressure monitoring in the design of antihypertensive drug trials.
    Coats AJ
    Blood Press Monit; 1996 Apr; 1(2):157-160. PubMed ID: 10226219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conduct of therapeutic trials.
    Vaïsse B
    Blood Press Monit; 1996 Jun; 1(3):237-240. PubMed ID: 10226235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring].
    Vaïsse B; Ghobrial H; Vaur L; Poncelet P; Asmar R; Herpin D; Mallion JM
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):907-12. PubMed ID: 11575229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Second-generation calcium antagonists and ambulatory blood pressure monitoring.
    Mallion JM; Baguet JP; Boutelant S; Tremel F; Siché JP; de Gaudemaris R
    J Cardiovasc Pharmacol; 1995; 25 Suppl 3():S17-22. PubMed ID: 8852540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory blood pressure monitoring in elderly hypertensive patients.
    Ravogli A; Zito M; Parati G; Abate G; Mancia G
    Clin Exp Hypertens; 1993; 15 Suppl 1():117-23. PubMed ID: 8513304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What are the approaches for evaluating antihypertensive treatment by 24 h ambulatory blood pressure monitoring?
    Neutel JM; Smith DH; Weber MA
    Blood Press Monit; 1999; 4 Suppl 2():S23-8. PubMed ID: 10822419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superior consistency of ambulatory blood pressure monitoring in children: implications for clinical trials.
    Gimpel C; Wühl E; Arbeiter K; Drozdz D; Trivelli A; Charbit M; Gellermann J; Dusek J; Jankauskiene A; Emre S; Schaefer F;
    J Hypertens; 2009 Aug; 27(8):1568-74. PubMed ID: 19550356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ambulatory blood pressure monitoring in the design of studies on antihypertensive drug efficacy.
    Mancia G; Omboni S; Parati G; Sega R; Trazzi S
    Am J Hypertens; 1993 Jun; 6(6 Pt 2):233S-235S. PubMed ID: 8347326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is it possible to file and approve a new antihypertensive without ambulatory blood pressure monitoring?
    Meyer-Sabellek WA
    Blood Press Monit; 1996 Jun; 1(3):317-319. PubMed ID: 10226253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods of data analysis of ambulatory blood pressure monitoring in clinical trials.
    de Gaudemaris R ; Chau NP
    Blood Press Monit; 1996 Jun; 1(3):259-262. PubMed ID: 10226240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of trough/peak ratio of indapamide 1.5 mg sustained-release form assessed by ambulatory blood pressure monitoring].
    Mallion JM; Asmar R; Ambrosioni E; MacMahon M; Coupez JM; de Cordoüe A; Barrandon S; Brault Y; Guez D; Safar M
    Arch Mal Coeur Vaiss; 1996 Sep; 89 Spec No 4():27-38. PubMed ID: 8952811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.